Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Februar 2025 08:00 ET | Quelle: Biogen Inc.

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments

Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights Collaboration broadens Biogen’s rare...
18. Februar 2025 08:00 ET | Quelle: ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting

Oral presentation on an efficacy study conducted in Japanese patients comparing anaphylaxis symptoms during oral food challenge with neffy as the initial treatment compared to site historical data on...
18. Februar 2025 08:00 ET | Quelle: Merus N.V.

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific...
18. Februar 2025 07:51 ET | Quelle: Lottery.com Inc.

Lottery.com Announces Global Advisory Board to Support Growth Initiatives

FORT WORTH, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or the “Company”), a leading technology company in digital lottery and sports...
18. Februar 2025 07:30 ET | Quelle: FTI Consulting, Inc.

FTI Consulting Expands Transactions Practice with Appointment of Two M&A Experts

WASHINGTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Emily Golenberg and Mitali Sharma as Senior Managing Directors in the Transactions...
18. Februar 2025 07:30 ET | Quelle: Opus Genetics, Inc.

Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be...
18. Februar 2025 07:30 ET | Quelle: TG Therapeutics, Inc.

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of presentations highlighting data from the ULTIMATE I & II Phase 3 trials and the...
18. Februar 2025 07:30 ET | Quelle: Future Market Insights Global and Consulting Pvt. Ltd.

Growing Demand for Downhole Tractors to Drive Global Market Growth at 5.8% CAGR from 2025 to 2035, Projected to Reach USD 7,088.4 Million | Future Market Insights, Inc.

NEWARK, Del, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to a Future Market Insights (FMI), the global downhole tractor market is projected to grow from USD 4,033.6 Million in 2025 to USD 7,088.4...
18. Februar 2025 07:30 ET | Quelle: FACT.MR

Dumping Hopper Market to Reach $4.25 Billion by 2035, Growing at 6.7% CAGR | Fact.MR Report

Rockville, MD, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global dumping hopper market was estimated at US$ 2,222 million in...
18. Februar 2025 07:30 ET | Quelle: Plus Therapeutics Inc.

Plus Therapeutics Secures $5.7 Million Financing to Support Leptomeningeal Metastases Program

Plus Therapeutics Secures $5.7 Million Financing to Support Leptomeningeal Metastases Program

Vorherige Seite

Nächste Seite